Effective use of real-life events as tools for teaching-learning clinical pharmacology in a problem-based learning curriculum
James, Henry
Effective use of real-life events as tools for teaching-learning clinical pharmacology in a problem-based learning curriculum - Vol.47(3), May-Jun - Mumbai Wolter Kluwer 2015 - 316-321p.
This paper describes how in a problem-based learning (PBL) medical curriculum, having identified the learning outcomes, problems can be developed from real-life events for teaching-learning clinical pharmacology topics for which PBL cases might be inadequate. Such problems can be very interesting and educational.
Methodology:
Using the story of the development and withdrawal of rofecoxib (Vioxx®), we developed a problem for undergraduate medical students to address important issues related to clinical pharmacology and therapeutics such as new drug development, preclinical testing, clinical trials, adverse drug reactions, professionalism, and critical appraisal of literature. These topics would otherwise be difficult to address in patient-based problems.
Results:
The evaluation of the problem based on pooled feedback from 57 tutorial groups, each comprising 8–10 students, collected over 5 years, supported the effectiveness of the problem.
Conclusion:
PHARMACOLOGY
Effective use of real-life events as tools for teaching-learning clinical pharmacology in a problem-based learning curriculum - Vol.47(3), May-Jun - Mumbai Wolter Kluwer 2015 - 316-321p.
This paper describes how in a problem-based learning (PBL) medical curriculum, having identified the learning outcomes, problems can be developed from real-life events for teaching-learning clinical pharmacology topics for which PBL cases might be inadequate. Such problems can be very interesting and educational.
Methodology:
Using the story of the development and withdrawal of rofecoxib (Vioxx®), we developed a problem for undergraduate medical students to address important issues related to clinical pharmacology and therapeutics such as new drug development, preclinical testing, clinical trials, adverse drug reactions, professionalism, and critical appraisal of literature. These topics would otherwise be difficult to address in patient-based problems.
Results:
The evaluation of the problem based on pooled feedback from 57 tutorial groups, each comprising 8–10 students, collected over 5 years, supported the effectiveness of the problem.
Conclusion:
PHARMACOLOGY